Phil Rolland

863 total citations
11 papers, 582 citations indexed

About

Phil Rolland is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Phil Rolland has authored 11 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Reproductive Medicine and 4 papers in Molecular Biology. Recurrent topics in Phil Rolland's work include Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Cancer-related Molecular Pathways (3 papers). Phil Rolland is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Cancer-related Molecular Pathways (3 papers). Phil Rolland collaborates with scholars based in United Kingdom, Australia and United States. Phil Rolland's co-authors include Lindy G. Durrant, Ian Spendlove, Suha Deen, Ian Scott, Timothy J. Duncan, Ian O. Ellis, Ahmad Al‐Attar, Robert Layfield, Zahra Madjd and Insiya Jafferji and has published in prestigious journals such as Clinical Cancer Research, International Journal of Cancer and Endocrine Related Cancer.

In The Last Decade

Phil Rolland

11 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phil Rolland United Kingdom	10	229	190	170	144	137	11	582
Alejandro Rojo‐Sebastián Spain	14	122 0.5×	375 2.0×	116 0.7×	142 1.0×	200 1.5×	18	686
Hongluan Mao China	14	129 0.6×	234 1.2×	62 0.4×	96 0.7×	80 0.6×	22	458
Elizabeth Kornaga Canada	11	255 1.1×	152 0.8×	77 0.5×	35 0.2×	95 0.7×	24	437
Jennifer Veneris United States	11	250 1.1×	174 0.9×	61 0.4×	162 1.1×	106 0.8×	33	492
Ingvild L. Tangen Norway	17	180 0.8×	257 1.4×	50 0.3×	200 1.4×	326 2.4×	26	684
L. Edwards Australia	7	142 0.6×	139 0.7×	33 0.2×	104 0.7×	54 0.4×	7	363
Haitham Arabi United States	12	67 0.3×	135 0.7×	32 0.2×	151 1.0×	152 1.1×	29	450
C Annicchiarico Italy	12	115 0.5×	136 0.7×	105 0.6×	119 0.8×	29 0.2×	20	357
Anna Berg Norway	16	167 0.7×	287 1.5×	44 0.3×	184 1.3×	256 1.9×	21	683
Henrica M.J. Werner Norway	13	114 0.5×	171 0.9×	35 0.2×	271 1.9×	431 3.1×	21	680

Countries citing papers authored by Phil Rolland

Since Specialization

Citations

This map shows the geographic impact of Phil Rolland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Rolland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Rolland more than expected).

Fields of papers citing papers by Phil Rolland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Rolland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Rolland. The network helps show where Phil Rolland may publish in the future.

Co-authorship network of co-authors of Phil Rolland

This figure shows the co-authorship network connecting the top 25 collaborators of Phil Rolland. A scholar is included among the top collaborators of Phil Rolland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil Rolland. Phil Rolland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Morrison, Jo, Peter Baldwin, Lynn Buckley, et al.. (2020). British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: Recommendations for practice. European Journal of Obstetrics & Gynecology and Reproductive Biology. 252. 502–525. 36 indexed citations

Donkers, Hannah, Jonathan Frost, Phil Rolland, et al.. (2020). Management of Malignant Vulval Melanoma: A Retrospective Case Series and Review of the Literature. Journal of Lower Genital Tract Disease. 24(3). 272–276. 7 indexed citations

Fotopoulou, Christina, Thomas Ind, Peter Baldwin, et al.. (2019). Sentinel lymph node consensus document of the British Gynaecological Cancer Society for endometrial, vulvar, and cervical cancers. International Journal of Gynecological Cancer. 29(9). 1348–1350. 14 indexed citations

Sundar, Sudha, Janos Balega, Emma J. Crosbie, et al.. (2017). BGCS uterine cancer guidelines: Recommendations for practice. European Journal of Obstetrics & Gynecology and Reproductive Biology. 213. 71–97. 108 indexed citations

Eagle, Robert A., et al.. (2010). ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients. International Journal of Cancer. 127(6). 1412–1420. 74 indexed citations

Duncan, Timothy J., Ahmad Al‐Attar, Phil Rolland, et al.. (2009). Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer. International Journal of Gynecological Pathology. 29(1). 8–18. 23 indexed citations

Duncan, Timothy J., Ahmad Al‐Attar, Phil Rolland, et al.. (2008). Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?. Clinical Cancer Research. 14(10). 3030–3035. 96 indexed citations

Rolland, Phil, Zahra Madjd, Lindy G. Durrant, et al.. (2007). The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease. Endocrine Related Cancer. 14(1). 73–80. 92 indexed citations

Duncan, Timothy J., Phil Rolland, Suha Deen, et al.. (2007). Loss of IFNγ Receptor Is an Independent Prognostic Factor in Ovarian Cancer. Clinical Cancer Research. 13(14). 4139–4145. 40 indexed citations

10.

Rolland, Phil, Suha Deen, Ian Scott, Lindy G. Durrant, & Ian Spendlove. (2007). Human Leukocyte Antigen Class I Antigen Expression Is an Independent Prognostic Factor in Ovarian Cancer. Clinical Cancer Research. 13(12). 3591–3596. 50 indexed citations

11.

Rolland, Phil, et al.. (2006). The p53 positive Bcl‐2 negative phenotype is an independent marker of prognosis in breast cancer. International Journal of Cancer. 120(6). 1311–1317. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact